Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT05954871 |
| Title | Study to Evaluate the Safety, Pharmacokinetics, and Activity of GDC-1971 in Combination With Either Osimertinib in Participants With Unresectable, Locally Advanced, or Metastatic Non-Small Cell Lung Cancer, or With Cetuximab in Participants With Metastatic Colorectal Cancer |
| Recruitment | Completed |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | Yes |
| Sponsors | Genentech, Inc. |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA | AUS |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| SCRI Oncology Partners | Nashville | Tennessee | 37203 | United States | Details | |
| START South Texas Accelerated Research Therapeutics-San Antonio | San Antonio | Texas | 78229 | United States | Details | |
| Border Medical Oncology | Wodonga | New South Wales | 3690 | Australia | Details | |
| St Vincent's Hospital Melbourne | Fitzroy | Victoria | 3065 | Australia | Details | |
| Seoul National University Hospital | Seoul | 03080 | South Korea | Details | ||
| Asan Medical Center | Seoul | 05505 | South Korea | Details |